Albert Seymour - 21 Apr 2022 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Role
President and Chief Scientific Officer
Signature
/s/ W. Bradford Smith, Attorney-in-Fact for Albert Seymour
Issuer symbol
QTTB
Transactions as of
21 Apr 2022
Net transactions value
$0
Form type
4
Filing time
21 Apr 2022, 17:31:10 UTC
Previous filing
28 Feb 2022
Next filing
08 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Employee Stock Option (Right to Buy) Award $0 +60,000 $0.000000 60,000 21 Apr 2022 Common Stock 60,000 $1.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following April 21, 2022.

Remarks:

President and Chief Scientific Officer